secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2026-05-21T21:00:44+00:00
Accession:  0001104659-26-065214
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VYNE and Yarrow publish investor presentation for proposed merger
-----------------------------------------------------------------

- Yarrow Bioscience published an investor presentation on May 21, 2026, now available on VYNE's website.
- VYNE previously filed Form S-4 (No. 333-294804) with proxy statement/prospectus for the proposed Yarrow acquisition.
- Presentation provides overview of Yarrow's business as part of the pending merger with VYNE.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926065214/0001104659-26-065214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926065214/tm2615387d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-065214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer